BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

680 related articles for article (PubMed ID: 19679152)

  • 1. Real-time electrochemical monitoring of drug release from therapeutic nanoparticles.
    Mora L; Chumbimuni-Torres KY; Clawson C; Hernandez L; Zhang L; Wang J
    J Control Release; 2009 Nov; 140(1):69-73. PubMed ID: 19679152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery.
    Lin A; Liu Y; Huang Y; Sun J; Wu Z; Zhang X; Ping Q
    Int J Pharm; 2008 Jul; 359(1-2):247-53. PubMed ID: 18457928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model.
    Beck-Broichsitter M; Gauss J; Packhaeuser CB; Lahnstein K; Schmehl T; Seeger W; Kissel T; Gessler T
    Int J Pharm; 2009 Feb; 367(1-2):169-78. PubMed ID: 18848609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of modified lipid nanoparticles for doxorubicin controlled release.
    Ying XY; Du YZ; Chen WW; Yuan H; Hu FQ
    Pharmazie; 2008 Dec; 63(12):878-82. PubMed ID: 19177903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A flexible drug delivery chip for the magnetically-controlled release of anti-epileptic drugs.
    Huang WC; Hu SH; Liu KH; Chen SY; Liu DM
    J Control Release; 2009 Nov; 139(3):221-8. PubMed ID: 19607866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional nanocarriers.
    Torchilin VP
    Adv Drug Deliv Rev; 2006 Dec; 58(14):1532-55. PubMed ID: 17092599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease.
    Pertuit D; Moulari B; Betz T; Nadaradjane A; Neumann D; Ismaïli L; Refouvelet B; Pellequer Y; Lamprecht A
    J Control Release; 2007 Nov; 123(3):211-8. PubMed ID: 17889397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of complexes of liposomes with gold nanoparticles.
    Kojima C; Hirano Y; Yuba E; Harada A; Kono K
    Colloids Surf B Biointerfaces; 2008 Oct; 66(2):246-52. PubMed ID: 18723331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescent nanoparticles of chitosan complex for real-time monitoring drug release.
    Cui W; Lu X; Cui K; Wu J; Wei Y; Lu Q
    Langmuir; 2011 Jul; 27(13):8384-90. PubMed ID: 21661743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.
    Gaumet M; Vargas A; Gurny R; Delie F
    Eur J Pharm Biopharm; 2008 May; 69(1):1-9. PubMed ID: 17826969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Core-modified chitosan-based polymeric micelles for controlled release of doxorubicin.
    Ye YQ; Yang FL; Hu FQ; Du YZ; Yuan H; Yu HY
    Int J Pharm; 2008 Mar; 352(1-2):294-301. PubMed ID: 18096336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptive micro and nanoparticles: temporal control over carrier properties to facilitate drug delivery.
    Yoo JW; Doshi N; Mitragotri S
    Adv Drug Deliv Rev; 2011 Nov; 63(14-15):1247-56. PubMed ID: 21605607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer drug delivery with nanoparticles.
    Conti M; Tazzari V; Baccini C; Pertici G; Serino LP; De Giorgi U
    In Vivo; 2006; 20(6A):697-701. PubMed ID: 17203748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticulate alternatives for drug delivery.
    Adair JH; Parette MP; Altinoğlu EI; Kester M
    ACS Nano; 2010 Sep; 4(9):4967-70. PubMed ID: 20873786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the use of novel drug delivery systems for antiretroviral drugs.
    Ojewole E; Mackraj I; Naidoo P; Govender T
    Eur J Pharm Biopharm; 2008 Nov; 70(3):697-710. PubMed ID: 18655830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug delivery systems: entering the mainstream.
    Allen TM; Cullis PR
    Science; 2004 Mar; 303(5665):1818-22. PubMed ID: 15031496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel method of doxorubicin-SPION reversible association for magnetic drug targeting.
    Munnier E; Cohen-Jonathan S; Linassier C; Douziech-Eyrolles L; Marchais H; Soucé M; Hervé K; Dubois P; Chourpa I
    Int J Pharm; 2008 Nov; 363(1-2):170-6. PubMed ID: 18687392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular drug delivery: nanomedicine applications.
    Vandervoort J; Ludwig A
    Nanomedicine (Lond); 2007 Feb; 2(1):11-21. PubMed ID: 17716187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micro- and nanoparticles--medical applications.
    Jătariu A; Peptu C; Popa M; Indrei A
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1160-9. PubMed ID: 20191893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of drug-loaded polymeric nanoparticles and evaluation of the antioxidant activity against lipid peroxidation.
    Pohlmann AR; Schaffazick SR; Creczynski-Pasa TB; Guterres SS
    Methods Mol Biol; 2010; 610():109-21. PubMed ID: 20013175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.